The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

NCT01627717 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

DRUG: Maraviroc (5 days)
DRUG: Maraviroc and boceprevir (14 days)

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborators

[object Object]
[object Object]
[object Object]